Skip Navigation
NCI banner National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer
Cancer Genome Characterization Initiative

Visit the database of genomic characterization data for multiple tumor types.

Association List

[Full Text]
Displaying Investigations 1 to 81 of 81 found
From 12 References


Asmann et al 2012, Cancer Res
  Adenocarcinoma Breast
GOLPH3L/CTSS
t(1;1)(q21;q21)

Babiceanu et al 2016, Nucleic Acids Res
  Nonneoplastic epithelial disorder/lesion Thyroid
NOTCH2NL/NBPF10
t(1;1)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Skin
NOTCH2NL/NBPF10
t(1;1)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Oesophagus
NOTCH2NL/NBPF10
t(1;1)(q21;q21)
  Nonneoplastic hematologic disorder/lesion
NOTCH2NL/NBPF10
t(1;1)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Bladder
NOTCH2NL/NBPF10
t(1;1)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Uterus, corpus
NOTCH2NL/NBPF10
t(1;1)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Large intestine
SLC39A1/CRTC2
t(1;1)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Gallbladder/Biliary system
SLC39A1/CRTC2
t(1;1)(q21;q21)
  Nonneoplastic hematologic disorder/lesion Lymph node
SLC39A1/CRTC2
t(1;1)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Bladder
SLC39A1/CRTC2
t(1;1)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Gallbladder/Biliary system
VPS45/PLEKHO1
t(1;1)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Gallbladder/Biliary system
VPS45/PLEKHO1
t(1;1)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Testis
VPS45/PLEKHO1
t(1;1)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Thyroid
VPS45/PLEKHO1
t(1;1)(q21;q21)

Chen et al 2013, Genome Biol
  Adenocarcinoma Breast
RPRD2/SHC1
t(1;1)(q21;q21)
  Adenocarcinoma Breast
SNX27/ADAR
t(1;1)(q21;q21)

Frattini et al 2013, Nat Genet
  Astrocytoma, grade III-IV/Glioblastoma Brain
PBXIP1/PMVK
t(1;1)(q21;q21)

Hammerman et al 2012, Nature
  Squamous cell carcinoma Lung
GATAD2B/PRKAB2
t(1;1)(q21;q21)

Hu et al 2018, Nucleic Acids Res
  Mesenchymal tumor, NOS Unknown site
ACP6/PIAS3
t(1;1)(q21;q21)
  Adenocarcinoma Pancreas
ADAM15/CHD1L
t(1;1)(q21;q21)
  Adenocarcinoma Prostate
ATP8B2/ADAR
t(1;1)(q21;q21)
  Squamous cell carcinoma Uterus, cervix
BCL9/GOLPH3L
t(1;1)(q21;q21)
  Transitional cell carcinoma Bladder
CERS2/SETDB1
t(1;1)(q21;q21)
  Adenocarcinoma Prostate
CHD1L/LCE1A
t(1;1)(q21;q21)
  Malignant epithelial tumor, special type Uterus, corpus
CHTOP/S100A1
t(1;1)(q21;q21)
  Transitional cell carcinoma Bladder
CHTOP/S100A13
t(1;1)(q21;q21)
  Adenocarcinoma Prostate
GATAD2B/LELP1
t(1;1)(q21;q21)
  Squamous cell carcinoma Unknown site
GNRHR2/S100A13
t(1;1)(q21;q21)
  Adenocarcinoma Liver
GOLPH3L/ARNT
t(1;1)(q21;q21)
  Mesenchymal tumor, NOS Unknown site
ITGA10/PEX11B
t(1;1)(q21;q21)
  Adenocarcinoma Stomach
NUDT17/POLR3C
t(1;1)(q21;q21)
  Malignant epithelial tumor, special type Uterus, corpus
NUP210L/TPM3
t(1;1)(q21;q21)
  Squamous cell carcinoma Lung
OTUD7B/HORMAD1
t(1;1)(q21;q21)
  Squamous cell carcinoma Lung
OTUD7B/CTSS
t(1;1)(q21;q21)
  Adenocarcinoma Breast
PI4KB/SELENBP1
t(1;1)(q21;q21)
  Adenocarcinoma Uterus, corpus
PMVK/PYGO2
t(1;1)(q21;q21)
  Mesenchymal tumor, NOS Unknown site
PRPF3/OTUD7B
t(1;1)(q21;q21)
  Transitional cell carcinoma Bladder
PRUNE/LCE4A
t(1;1)(q21;q21)
  Transitional cell carcinoma Bladder
PRUNE/LCE2A
t(1;1)(q21;q21)
  Adenocarcinoma Uterus, corpus
PRUNE/PI4KB
t(1;1)(q21;q21)
  Squamous cell carcinoma Lung
RNF115/PIAS3
t(1;1)(q21;q21)
  Malignant melanoma Skin
RNF115/PRPF3
t(1;1)(q21;q21)
  Mesenchymal tumor, NOS Unknown site
RPRD2/LCE1C
t(1;1)(q21;q21)
  Adenocarcinoma Breast
RPRD2/CA14
t(1;1)(q21;q21)
  Transitional cell carcinoma Bladder
VPS72/GABPB2
t(1;1)(q21;q21)

Nik-Zainal et al 2016, Nature
  Adenocarcinoma Breast
GOLPH3L/HORMAD1
t(1;1)(q21;q21)

Rudin et al 2012, Nat Genet
  Undifferentiated carcinoma, small cell Lung
TXNIP/NOTCH2NL
t(1;1)(q21;q21)

Sakarya et al 2012, PLoS Comput Biol
  Adenocarcinoma Breast
GATAD2B/NUP210L
t(1;1)(q21;q21)

Teles Alves et al 2015, Oncogene
  Adenocarcinoma Prostate
GABPB2/BNIPL
t(1;1)(q21;q21)

The Cancer Genome 2013, N Engl J Med
  Acute myeloblastic leukemia with maturation (FAB type M2)
CRTC2/CREB3L4
t(1;1)(q21;q21)

Yoshihara et al 2015, Oncogene
  Adenocarcinoma Thyroid
INTS3/CHTOP
t(1;1)(q21;q21)
  Malignant melanoma Skin
CTSS/TDRD10
t(1;1)(q21;q21)
  Adenocarcinoma Ovary
GATAD2B/NUP210L
t(1;1)(q21;q21)
  Adenocarcinoma Ovary
ANP32E/CTSK
t(1;1)(q21;q21)
  Adenocarcinoma Prostate
GATAD2B/KCNN3
t(1;1)(q21;q21)
  Squamous cell carcinoma Lung
TARS2/VPS45
t(1;1)(q21;q21)
  Adenocarcinoma Ovary
GOLPH3L/HORMAD1
t(1;1)(q21;q21)
  Adenocarcinoma Ovary
GATAD2B/CRTC2
t(1;1)(q21;q21)
  Adenocarcinoma Ovary
MCL1/CTSS
t(1;1)(q21;q21)
  Adenocarcinoma Ovary
GABPB2/MLLT11
t(1;1)(q21;q21)
  Squamous cell carcinoma Lung
PIP5K1A/TNFAIP8L2
t(1;1)(q21;q21)
  Squamous cell carcinoma Lung
RPRD2/BOLA1
t(1;1)(q21;q21)
  Adenocarcinoma Lung
SETDB1/PLEKHO1
t(1;1)(q21;q21)
  Adenocarcinoma Lung
PRPF3/CTSS
t(1;1)(q21;q21)
  Adenocarcinoma Lung
ARNT/RIIAD1
t(1;1)(q21;q21)
  Adenocarcinoma Lung
PIP5K1A/C1orf56
t(1;1)(q21;q21)
  Adenocarcinoma Lung
VPS72/RORC
t(1;1)(q21;q21)
  Adenocarcinoma Lung
SNAPIN/S100A1
t(1;1)(q21;q21)
  Astrocytoma, grade I-II Brain
RPRD2/S100A2
t(1;1)(q21;q21)
  Squamous cell carcinoma Oral cavity
TUFT1/CGN
t(1;1)(q21;q21)
  Adenocarcinoma Breast
SHC1/RPRD2
t(1;1)(q21;q21)
  Adenocarcinoma Breast
RPRD2/SHC1
t(1;1)(q21;q21)
  Adenocarcinoma Breast
PRUNE/C1orf54
t(1;1)(q21;q21)
  Adenocarcinoma Breast
PIP5K1A/MLLT11
t(1;1)(q21;q21)
  Adenocarcinoma Breast
RPRD2/VPS45
t(1;1)(q21;q21)
  Adenocarcinoma Breast
BCL9/SMCP
t(1;1)(q21;q21)
  Adenocarcinoma Breast
BCL9/IVL
t(1;1)(q21;q21)
  Adenocarcinoma Breast
SNX27/ADAR
t(1;1)(q21;q21)
  Adenocarcinoma Breast
THEM4/S100A10
t(1;1)(q21;q21)
  Transitional cell carcinoma Bladder
ANXA9/MRPL9
t(1;1)(q21;q21)